ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
Dow Jones
42.906,95
0,16%
Euro vs US Dollar
1,03949
-0,10%
Bitcoin
94.411,90
-0,29%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Pharming Group NV (PHAR) Börsenkurse

Pharming Group NV

Pharming Group NV (PHAR)

Pharos Energy Plc
10,43
1,33
(14,62%)
Geschlossen 24 Dezember 10:00PM
Verzögert um 15 Minuten
10,43
0,00
(0,00%)
Nach Börsenschluss: 9:59PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
10,43
Gebot
9,08
Fragen
10,64
Volumen
16.061
9,10 Tagesbereich 10,4488
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
699,929M
Handelsende
9,10
Handelsbeginn
9,50
Letzte Trade
2
@
10.25
Letzter Handelszeitpunkt
Finanzvolumen
US$ 155.151
VWAP
9,6601
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
67.107.324
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,53
Gewinn pro Aktie (EPS)
-0,16
Erlöse
245,32M
Nettogewinn
-10,55M

Über Pharming Group NV

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. Pharming Group is engaged in the development of products for the treatment of unmet medical needs.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Diversified
Website
www.pharming.com
Hauptsitz
Leiden, South Holland, Nld
Gegründet
1988
Pharming Group NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHAR. The last closing price for Pharming Group NV was US$9,10. Over the last year, Pharming Group NV shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Pharming Group NV currently has 67.107.324 shares in issue. The market capitalisation of Pharming Group NV is US$610,68 million. Pharming Group NV has a price to earnings ratio (PE ratio) of -5.53.

PHAR Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

30 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

08 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

08 Januar 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Oktober 2023
Edgar (US Regulatory)

Pharming Group to participate in September investor conferences

Pharming Group to participate in September investor conferences PR Newswire LEIDEN, The Netherlands, Aug. 24, 2023 LEIDEN, The Netherlands, Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V...

24 August 2023
PR Newswire (US)

Pharming Group to convene Extraordinary General Meeting of Shareholders

Pharming Group to convene Extraordinary General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands, Aug. 14, 2023 LEIDEN, The Netherlands, Aug. 14, 2023 /PRNewswire/ -- Pharming Group...

14 August 2023
PR Newswire (US)

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan PR Newswire LEIDEN, The Netherlands, Aug. 9, 2023 Single-arm Phase III study...

09 August 2023
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

PHAR - Frequently Asked Questions (FAQ)

What is the current Pharming Group NV share price?
The current share price of Pharming Group NV is US$ 10,43
How many Pharming Group NV shares are in issue?
Pharming Group NV has 67.107.324 shares in issue
What is the market cap of Pharming Group NV?
The market capitalisation of Pharming Group NV is USD 610,68M
What is the 1 year trading range for Pharming Group NV share price?
Pharming Group NV has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Pharming Group NV?
The price to earnings ratio of Pharming Group NV is -5,53
What is the cash to sales ratio of Pharming Group NV?
The cash to sales ratio of Pharming Group NV is 0,24
What is the reporting currency for Pharming Group NV?
Pharming Group NV reports financial results in USD
What is the latest annual turnover for Pharming Group NV?
The latest annual turnover of Pharming Group NV is USD 245,32M
What is the latest annual profit for Pharming Group NV?
The latest annual profit of Pharming Group NV is USD -10,55M
What is the registered address of Pharming Group NV?
The registered address for Pharming Group NV is VONDELLAAN 47, LEIDEN, SOUTH HOLLAND, 2332 AA
What is the Pharming Group NV website address?
The website address for Pharming Group NV is www.pharming.com
Which industry sector does Pharming Group NV operate in?
Pharming Group NV operates in the PHARMACEUTICAL DIVERSIFIED sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DRCTDirect Digital Holdings Inc
US$ 5,25
(854,55%)
68,54M
CHEKCheck Cap Ltd
US$ 2,24
(279,66%)
40,03M
SLGLSol Gel Technologies Ltd
US$ 1,57
(265,97%)
18,2M
RELIReliance Global Group Inc
US$ 3,08
(156,67%)
105,56M
TRAWTraws Pharma Inc
US$ 12,50
(149,00%)
28,23M
AILEiLearningEngines Inc
US$ 0,199
(-77,51%)
29,71M
MGOLMGO Global Inc
US$ 0,4765
(-49,84%)
14,17M
YHCLQR House Inc
US$ 1,11
(-36,57%)
1,28M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4014
(-34,37%)
195,36M
ADGMAdagio Medical Holdings Inc
US$ 1,095
(-33,64%)
4,84M
EDBLEdible Garden AG Inc
US$ 0,3669
(54,35%)
408,02M
RGTIRigetti Computing Inc
US$ 10,945
(16,81%)
223,51M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4014
(-34,37%)
192,3M
NVDANVIDIA Corporation
US$ 139,67
(3,69%)
174,65M
RIMEAlgorhythm Holdings Inc
US$ 0,0925
(21,07%)
155,8M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
PHAR
Pharming Group NV
BIT
Q00288
Leonteq Securities
BIT
AF
Air France KLM
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten